國家衛生研究院 NHRI:Item 3990099045/9604

NHRI > Institute of Biotechnology and Pharmaceutical Research > Hsing-Pang Hsieh > Conference Papers/Meeting Abstract > Item 3990099045/9604

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9604

Title:	BPR2P001S0, a Coumarin derivative, induced cell cycle arrest in A549 through inhibiting PDPK1 activity
Authors:	Lin, PH;Jao, TM;Hung, YL;Hsieh, HP;Yang, YC;Chang, SY
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	Lung cancer is one of the most common causes of cancer deaths in the world, and the emergence of resistant lung cancer cells can lead to treatment failure. The development of new drugs to treat lung cancer, especially those resistant lung cancer cells, is urgent. Previously we identified that coumarin could inhibit replication of human lung cancer A549 cells. The efficacy of 284 coumarin derivatives on human lung cancer A549 cells was examined, and BPR2P001S0 was the most potent compound. BPR2P001S0 exhibited growth inhibition and apoptotic activity on A549 cells with an IC50 of 10 nM. A similar level of inhibitory effects was also observed in cisplatin-resistant A549 cells (IC50 = 12.5 nM). The ability of colony formation and migration capability of A549 cells decreased significantly in the presence of BPR2P001S0. In cell cycle analysis, BPR2P001S0 induced cell cycle arrest at the G0/G1 phase through down-regulation of cyclin D1 and Cdk4 protein expression. The expression of cyclinD1/Cdk4 regulatory protein, Akt, was also decreased. Subsequently, we found that the expression level of Ser241 phosphorated PDPK1 protein, an Akt activator in Akt pathway, was also reduced. By molecular docking analysis, we found that the reduced PDPK1 phosphorylation is likely resulted from the allosteric effect of interactions between BPRHIV001 and PDPK1. In conclusion, our results suggest that the anti-tumor activity of BPR2P001S0 is likely resulting from its ability to interfere with PDPK1 autophosphorylation at Ser241, which leads to reduced Akt protein and subsequent cyclin D1 degradation.
Date:	2015-08
Relation:	Cancer Research. 2015 Aug;75:Abstract number 1754.
Link to:	http://dx.doi.org/10.1158/1538-7445.am2015-1754
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0008-5472&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000371578503239
Appears in Collections:	[Hsing-Pang Hsieh] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000371578503239.pdf		28Kb	Adobe PDF	417	View/Open

Loading...